IL6 and nonpapillary renal cell carcinoma: Having demonstrated that TTC13 activated Wnt/β-catenin and IL6-JAK-STAT3 signal pathways in ccRCC, we speculated that TTC13 might contribute to ccRCC progression through the above two signaling pathways.